Forte Biosciences Inc. (FBRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Forte Biosciences Inc.

    NASDAQ: FBRX · Real-Time Price · USD
    15.49
    2.05 (15.25%)
    At close: Oct 03, 2025, 3:59 PM
    15.19
    -1.94%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    Forte Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 39K 9K n/a 36K
    Gross Profit
    		 -39K -9K n/a -36K
    Operating Income
    		 -36.6M -32.49M -13.9M -21.49M
    Interest Income
    		 1.31M 1.12M n/a n/a
    Pretax Income
    		 -35.48M -31.48M -13.88M -21.71M
    Net Income
    		 -35.48M -31.48M -13.86M -21.71M
    Selling & General & Admin
    		 15.41M 10.62M 8.3M 7.63M
    Research & Development
    		 20.71M 21.86M 5.59M 13.85M
    Other Expenses
    		 479K -0.00 17K n/a
    Operating Expenses
    		 36.6M 32.48M 13.9M 21.49M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a -9K n/a n/a
    Cost & Expenses
    		 -36.6M 32.49M 13.9M 21.49M
    Income Tax Expense
    		 n/a n/a -17K -200.56K
    Shares Outstanding (Basic)
    		 2.92M 1.26M 695.34K 558.71K
    Shares Outstanding (Diluted)
    		 2.92M 1.26M 695.34K 558.71K
    EPS (Basic)
    		 -12.17 -24.92 -19.96 -38.85
    EPS (Diluted)
    		 -12.17 -24.92 -19.96 -38.85
    EBITDA
    		 -35.44M -32.48M -13.9M -21.45M
    EBIT
    		 -35.48M -32.49M -13.9M -21.49M
    Depreciation & Amortization
    		 39K 9K 36K 36K

    Add to Watchlist